PubMed=21544390; DOI=10.3892/ijo.8.3.513
Pfragner R., Wirnsberger G.H., Niederle B., Behmel A., Rinner I., Mandl A., Wawrina F., Luo J.-S., Adamiker D., Hoger H., Ingolic E., Schauenstein K.
Establishment of a continuous cell line from a human carcinoid of the small intestine (KRJ-I).
Int. J. Oncol. 8:513-520(1996)

PubMed=17242179; DOI=10.1677/jme.1.02037
Kidd M., Eick G.N., Modlin I.M., Pfragner R., Champaneria M.C., Murren J.R.
Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin.
J. Mol. Endocrinol. 38:181-192(2007)

PubMed=19295186; DOI=10.1159/000209330
Siddique Z.-L., Drozdov I., Floch J., Gustafsson B.I., Stunes K., Pfragner R., Kidd M., Modlin I.M.
KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model.
Neuroendocrinology 89:458-470(2009)

PubMed=22538498; DOI=10.1159/000338793
Grozinsky-Glasberg S., Shimon I., Rubinfeld H.
The role of cell lines in the study of neuroendocrine tumors.
Neuroendocrinology 96:173-187(2012)

PubMed=23119007; DOI=10.1371/journal.pone.0048411; PMCID=PMC3485222
Li S.-C., Martijn C., Cui T., Essaghir A., Luque R.M., Demoulin J.-B., Castano J.P., Oberg K.E., Giandomenico V.
The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells.
PLoS ONE 7:E48411-E48411(2012)

PubMed=29444910; DOI=10.1530/ERC-17-0445; PMCID=PMC5827037
Hofving T., Arvidsson Y., Almobarak B., Inge L., Pfragner R., Persson M., Stenman G., Kristiansson E., Johanson V., Nilsson O.
The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.
Endocr. Relat. Cancer 25:367-380(2018)

PubMed=31548718; DOI=10.1038/s41588-019-0490-z
Hofving T., Karlsson J.W., Nilsson O., Nilsson J.A.
H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines.
Nat. Genet. 51:1426-1427(2019)

PubMed=31548719; DOI=10.1038/s41588-019-0509-5; PMCID=PMC7256901
Alvarez M.J., Yan P.-R., Alpaugh M.L., Bowden M., Sicinska E.T., Zhou C.-S.W., Karan C., Realubit R.B., Mundi P.S., Grunn A., Jager D., Chabot J.A., Fojo A.T., Oberstein P.E., Hibshoosh H., Milsom J.W., Kulke M.H., Loda M., Chiosis G., Reidy-Lagunes D.L., Califano A.
Reply to 'H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines'.
Nat. Genet. 51:1427-1428(2019)